These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3766750)

  • 1. Direct cardiac effects of vasopressin and their reversal by a vascular antagonist.
    Boyle WA; Segel LD
    Am J Physiol; 1986 Oct; 251(4 Pt 2):H734-41. PubMed ID: 3766750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors.
    Walker BR; Childs ME; Adams EM
    Am J Physiol; 1988 Aug; 255(2 Pt 2):H261-5. PubMed ID: 2970231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of arginine vasopressin on isolated guinea pig heart function during perfusion at constant flow and constant pressure.
    Graf BM; Fischer B; Martin E; Bosnjak ZJ; Stowe DF
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):1-7. PubMed ID: 9007663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart.
    Ouattara A; Landi M; Le Manach Y; Lecomte P; Leguen M; Boccara G; Coriat P; Riou B
    Anesthesiology; 2005 Jan; 102(1):85-92. PubMed ID: 15618791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of vasopressin-mediated coronary constriction and myocardial depression in the hypoxic heart.
    Boyle WA; Segel LD
    Circ Res; 1990 Mar; 66(3):710-21. PubMed ID: 2306803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of vasopressin-induced coronary artery constriction by the vasopressin antagonist d(CH2)5Tyr(Me)-AVP.
    Kopia GA; Valocik RE
    J Cardiovasc Pharmacol; 1985; 7(5):958-63. PubMed ID: 2413308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of selective arginine vasopressin V1 and V2 receptor antagonists on burn shock in the rat.
    Sun K; Lin BC; Wang CH; Zhu HN
    Cardiovasc Res; 1991 Apr; 25(4):265-9. PubMed ID: 1884385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia.
    Müller S; How OJ; Hermansen SE; Stenberg TA; Sager G; Myrmel T
    Crit Care; 2008; 12(1):R20. PubMed ID: 18291025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasopressin on left ventricular performance.
    Cheng CP; Igarashi Y; Klopfenstein HS; Applegate RJ; Shihabi Z; Little WC
    Am J Physiol; 1993 Jan; 264(1 Pt 2):H53-60. PubMed ID: 8430861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin.
    Yared A; Kon V; Ichikawa I
    J Clin Invest; 1985 May; 75(5):1477-87. PubMed ID: 3998146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norepinephrine amplifies effects of vasopressin on the isolated rat heart.
    Derad I; Pauschinger P; Born J
    Regul Pept; 1992 Apr; 39(1):35-41. PubMed ID: 1579658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin lowers pulmonary artery pressure in hypoxic rats by releasing atrial natriuretic peptide.
    Jin HK; Chen YF; Yang RH; McKenna TM; Jackson RM; Oparil S
    Am J Med Sci; 1989 Oct; 298(4):227-36. PubMed ID: 2529763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of vasopressin in isolated rat hearts.
    Kaygisiz Z; Kabadere TE; Dernek S; Erden SH
    Indian J Physiol Pharmacol; 2001 Jan; 45(1):54-62. PubMed ID: 11211571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin-induced pulmonary vasodilation in rats.
    Walker BR; Haynes J; Wang HL; Voelkel NF
    Am J Physiol; 1989 Aug; 257(2 Pt 2):H415-22. PubMed ID: 2764128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective vasopressin inhibition in rats with heart failure decreases afterload and results in venodilatation.
    Raya TE; Gay RG; Goldman S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1015-20. PubMed ID: 2262890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of impaired cardiac function by vasopressin.
    Wilson MF; Brackett DJ; Archer LT; Hinshaw LB
    Ann Surg; 1980 Apr; 191(4):494-500. PubMed ID: 7369815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin in vasodilatory shock: is the heart in danger?
    Hauser B; Asfar P; Calzia E; Laporte R; Georgieff M; Radermacher P
    Crit Care; 2008; 12(2):132. PubMed ID: 18423065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 8-bromo-cyclic guanosine monophosphate (cGMP) on coronary artery constriction in isolated rabbit hearts.
    Bing RJ; Saeed M
    J Am Coll Cardiol; 1986 Aug; 8(2):342-8. PubMed ID: 3016062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery.
    Clineschmidt BV; Lis EV
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):72-84. PubMed ID: 2950833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary vasoactive effects of exogenous and endogenous AVP in conscious dogs.
    Nyhan DP; Geller HS; Goll HM; Murray PA
    Am J Physiol; 1986 Nov; 251(5 Pt 2):H1009-16. PubMed ID: 3022606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.